▲ Peaking
Health
Edible batteries power medical devices in the body
Edible batteries are emerging as a power source for medical devices operating inside the human body.
Medical Devices
10 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Health
A new battery could make edible electronics safer
Recent coverage highlights a new paper battery prototype designed to power ingestible medical devices safely inside the body.
◼ Archived
Business
🔮 fades ✓
J&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports
Apollo is reportedly in talks to acquire Johnson & Johnson's hips-and-knees orthopedics business in a potential twenty billion dollar deal.
◼ Archived
Business
🔮 fades ✗
Boston Scientific Won’t Meet Guidance Due to Cyberattack
Boston Scientific faces financial fallout and missed guidance following a recent cyberattack.
◼ Archived
Business
🔮 holds ✗
Will Autonomous AI Exceed AI-Aided Physicians as the Best Medical Care?
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Technology
🔮 fades ✓
Smartwatches are getting smarter. Is healthcare ready?
4 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
KKR to Buy Integer Holdings for $4.3 Billion in Cash
Investment giant KKR is moving to take medical device manufacturer Integer Holdings private in a multi-billion dollar cash acquisition.
◼ Archived
Business
🔮 fades
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories boosts its 2026 full-year profit guidance after reporting stronger-than-expected second-quarter sales and earnings.
◼ Archived
Health
🔮 fades
Scientists Created a Wearable You Can Paint Directly Onto Your Skin
Researchers have developed paintable electrodes that allow flexible, colorful wearable sensors to be applied directly to the skin.
◼ Archived
Business
🔮 fades
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Novo Nordisk and Vivani are partnering to develop a long-acting semaglutide implant designed to improve weight loss adherence for up to a year.